• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MOZ/MLL 介导的转录激活系统在正常造血和白血病发生中的自我更新作用。

Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis.

机构信息

Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Japan.

National Cancer Center Research Institute, Tokyo, Japan.

出版信息

FEBS J. 2022 Dec;289(24):7987-8002. doi: 10.1111/febs.16180. Epub 2021 Sep 16.

DOI:10.1111/febs.16180
PMID:34482632
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10078767/
Abstract

Homeostasis in the blood system is maintained by the balance between self-renewing stem cells and nonstem cells. To promote self-renewal, transcriptional regulators maintain epigenetic information during multiple rounds of cell division. Mutations in such transcriptional regulators cause aberrant self-renewal, leading to leukemia. MOZ, a histone acetyltransferase, and MLL, a histone methyltransferase, are transcriptional regulators that promote the self-renewal of hematopoietic stem cells. Gene rearrangements of MOZ and MLL generate chimeric genes encoding fusion proteins that function as constitutively active forms. These MOZ and MLL fusion proteins constitutively activate transcription of their target genes and cause aberrant self-renewal in committed hematopoietic progenitors, which normally do not self-renew. Recent progress in the field suggests that MOZ and MLL are part of a transcriptional activation system that activates the transcription of genes with nonmethylated CpG-rich promoters. The nonmethylated state of CpGs is normally maintained during cell divisions from the mother cell to the daughter cells. Thus, the MOZ/MLL-mediated transcriptional activation system replicates the expression profile of mother cells in daughter cells by activating the transcription of genes previously transcribed in the mother cell. This review summarizes the functions of the components of the MOZ/MLL-mediated transcriptional activation system and their roles in the promotion of self-renewal.

摘要

血液系统中的内稳定是通过自我更新干细胞和非干细胞之间的平衡来维持的。为了促进自我更新,转录调节因子在多次细胞分裂过程中维持表观遗传信息。这种转录调节因子的突变导致异常的自我更新,导致白血病。MOZ,一种组蛋白乙酰转移酶,和 MLL,一种组蛋白甲基转移酶,是促进造血干细胞自我更新的转录调节因子。MOZ 和 MLL 的基因重排产生编码融合蛋白的嵌合基因,这些融合蛋白作为组成型激活形式发挥作用。这些 MOZ 和 MLL 融合蛋白组成型激活其靶基因的转录,并导致通常不自更新的定向造血祖细胞的异常自我更新。该领域的最新进展表明,MOZ 和 MLL 是转录激活系统的一部分,该系统激活具有非甲基化 CpG 丰富启动子的基因的转录。CpG 的非甲基化状态通常在从母细胞到子细胞的细胞分裂过程中得到维持。因此,MOZ/MLL 介导的转录激活系统通过激活在母细胞中先前转录的基因的转录,在子细胞中复制母细胞的表达谱。这篇综述总结了 MOZ/MLL 介导的转录激活系统的组成部分的功能及其在促进自我更新中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/f62234342121/FEBS-289-7987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/1714194ab0ec/FEBS-289-7987-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/e2c1e1ae1c13/FEBS-289-7987-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/e8d7ceccbb7d/FEBS-289-7987-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/58b1f2ce6875/FEBS-289-7987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/f62234342121/FEBS-289-7987-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/1714194ab0ec/FEBS-289-7987-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/e2c1e1ae1c13/FEBS-289-7987-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/e8d7ceccbb7d/FEBS-289-7987-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/58b1f2ce6875/FEBS-289-7987-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0295/10078767/f62234342121/FEBS-289-7987-g003.jpg

相似文献

1
Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis.MOZ/MLL 介导的转录激活系统在正常造血和白血病发生中的自我更新作用。
FEBS J. 2022 Dec;289(24):7987-8002. doi: 10.1111/febs.16180. Epub 2021 Sep 16.
2
Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.通过 MLL/AEP 介导的转录激活系统的异常自我更新导致白血病发生。
Cancer Sci. 2021 Oct;112(10):3935-3944. doi: 10.1111/cas.15054. Epub 2021 Aug 2.
3
Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.CpG 丰富启动子的激活由 MLL 介导驱动 MOZ 重排白血病。
Cell Rep. 2020 Sep 29;32(13):108200. doi: 10.1016/j.celrep.2020.108200.
4
Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.白血病相关蛋白 MOZ 和 MLL 之间的串扰调节人脐血 CD34+细胞中 HOX 基因的表达。
Oncogene. 2010 Sep 9;29(36):5019-31. doi: 10.1038/onc.2010.254. Epub 2010 Jun 28.
5
[The mechanism of MLL-rearranged leukemogenesis and its targeted therapies].[MLL重排白血病发生机制及其靶向治疗]
Rinsho Ketsueki. 2021;62(8):988-997. doi: 10.11406/rinketsu.62.988.
6
Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.组蛋白乙酰转移酶单核细胞白血病锌指蛋白在正常和恶性造血中的作用。
Cancer Sci. 2008 Aug;99(8):1523-7. doi: 10.1111/j.1349-7006.2008.00865.x.
7
Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.Symplekin是一种聚腺苷酸化因子,可抑制造血细胞中MOZ和MLL对HOXA9的活性。
Biochim Biophys Acta. 2013 Dec;1833(12):3054-3063. doi: 10.1016/j.bbamcr.2013.08.013. Epub 2013 Aug 27.
8
MOZ is essential for maintenance of hematopoietic stem cells.MOZ对造血干细胞的维持至关重要。
Genes Dev. 2006 May 15;20(10):1321-30. doi: 10.1101/gad.1393106.
9
MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.MOZ 对于 MOZ/MLL 融合诱导的白血病的发展至关重要,通过调节 Hoxa9/Meis1 的表达。
Blood Adv. 2022 Oct 11;6(19):5527-5537. doi: 10.1182/bloodadvances.2020003490.
10
HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.HBO1-MLL 相互作用促进 AF4/ENL/P-TEFb 介导的白血病发生。
Elife. 2021 Aug 25;10:e65872. doi: 10.7554/eLife.65872.

引用本文的文献

1
A multivalent engagement of ENL with MOZ.ENL与MOZ的多价结合。
Nat Struct Mol Biol. 2025 Apr;32(4):709-718. doi: 10.1038/s41594-024-01455-8. Epub 2025 Jan 10.
2
HBO1, a MYSTerious KAT and its links to cancer.HBO1,一个神秘的 KAT 及其与癌症的联系。
Biochim Biophys Acta Gene Regul Mech. 2024 Sep;1867(3):195045. doi: 10.1016/j.bbagrm.2024.195045. Epub 2024 Jun 6.
3
MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.MOZ/ENL 复合物是白血病 AF10 融合蛋白的募集因子。

本文引用的文献

1
Myeloid Progenitor Transformation Assay.髓系祖细胞转化试验
Bio Protoc. 2017 Dec 5;7(23):e2626. doi: 10.21769/BioProtoc.2626.
2
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia.急性白血病中ENL/AF9 YEATS结构域的化学抑制作用
ACS Cent Sci. 2021 May 26;7(5):815-830. doi: 10.1021/acscentsci.0c01550. Epub 2021 Apr 30.
3
Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.CpG 丰富启动子的激活由 MLL 介导驱动 MOZ 重排白血病。
Nat Commun. 2023 Apr 8;14(1):1979. doi: 10.1038/s41467-023-37712-5.
4
The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer.组蛋白修饰在 DNA 复制偶联核小体组装和癌症中的作用。
Int J Mol Sci. 2023 Mar 3;24(5):4939. doi: 10.3390/ijms24054939.
Cell Rep. 2020 Sep 29;32(13):108200. doi: 10.1016/j.celrep.2020.108200.
4
KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.KAT7 是由 MLL 重排驱动的急性髓系白血病的遗传脆弱性。
Leukemia. 2021 Apr;35(4):1012-1022. doi: 10.1038/s41375-020-1001-z. Epub 2020 Aug 6.
5
The molecular functions of common and atypical MLL fusion protein complexes.常见和非典型 MLL 融合蛋白复合物的分子功能。
Biochim Biophys Acta Gene Regul Mech. 2020 Jul;1863(7):194548. doi: 10.1016/j.bbagrm.2020.194548. Epub 2020 Apr 19.
6
Cell-Based Ligand Discovery for the ENL YEATS Domain.基于细胞的 ENL YEATS 结构域配体发现。
ACS Chem Biol. 2020 Apr 17;15(4):895-903. doi: 10.1021/acschembio.0c00124. Epub 2020 Mar 19.
7
Therapeutic targeting of preleukemia cells in a mouse model of mutant acute myeloid leukemia.在一个突变型急性髓系白血病的小鼠模型中对白血病前细胞进行治疗性靶向。
Science. 2020 Jan 31;367(6477):586-590. doi: 10.1126/science.aax5863.
8
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia.Menin 抑制剂 MI-3454 诱导 MLL1 重排和 NPM1 突变的白血病模型缓解。
J Clin Invest. 2020 Feb 3;130(2):981-997. doi: 10.1172/JCI129126.
9
HBO1 is required for the maintenance of leukaemia stem cells.HBO1 对于白血病干细胞的维持是必需的。
Nature. 2020 Jan;577(7789):266-270. doi: 10.1038/s41586-019-1835-6. Epub 2019 Dec 11.
10
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.一种 Menin-MLL 抑制剂可诱导特定的染色质变化,并消除 MLL 重排白血病模型中的疾病。
Cancer Cell. 2019 Dec 9;36(6):660-673.e11. doi: 10.1016/j.ccell.2019.11.001.